Initial testing (Stage 1) of AT13387, an HSP90 inhibitor, by the pediatric preclinical testing program.
Kang MH; Reynolds CP; Houghton PJ; Alexander D; Morton CL; Kolb EA; Gorlick R; Keir ST; Carol H; Lock R; Maris JM; Wozniak A; Smith MA; Pediatric Blood & Cancer, 2012, vol. 59, issue 1, p 185, ISSN 15455017. ISBN 15455017.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef